USE OF MTOR INHIBITORS FOR PREVENTION OF NEUROENDOCRINE TUMOR DEVELOPMENT AND GROWTH

摘要

Disclosed are methods and compositions for the prevention or inhibition of the growth of endocrine-related adenomas, neoplasia, or dysplasia in a patient who has been identified as being at risk for developing an endocrine tumor or endocrine cancer. The disclosed methods and compositions include rapamycin, a rapamycin analog, or another such inhibitor of the target of rapamycin (TOR).